FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

726519005: Brodalumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3450091013 Brodalumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3450092018 Brodalumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
795711000172115 brodalumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brodalumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Brodalumab (substance) Is a Interleukin receptor antagonist true Inferred relationship Some
Brodalumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Interleukin receptor antagonist (disposition) true Inferred relationship Some
Brodalumab (substance) Is a Immunologic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing brodalumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Brodalumab (substance) Inferred relationship Some 1
Brodalumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Brodalumab (substance) Inferred relationship Some 1
Brodalumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Brodalumab (substance) Inferred relationship Some 1
Brodalumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Brodalumab (substance) Inferred relationship Some 1
Product containing precisely brodalumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Brodalumab (substance) Inferred relationship Some 1
Product containing precisely brodalumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Brodalumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start